Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men between 40 and 70 years of age
- People who have had Type 2 diabetes for more than 6 months, as defined by recognised diabetes guidelines
- People whose diabetes may be uncomplicated, or may involve certain related conditions such as eye disease, kidney disease (with kidney function above a certain level), blood vessel disease in the legs, heart disease, or stroke
- People who also have high LDL cholesterol levels or a history of smoking (past or current)
- People whose diabetes is either well-controlled (HbA1c below 8%) or poorly controlled (HbA1c above 9%), based on their individual treatment goals
- People who may or may not be using insulin injections as part of their diabetes treatment
- People whose diabetes treatment includes at least one medication from a group called SGLT2 inhibitors (confirm with trial site if unsure whether a current medication falls into this category)
- People who are members of the French national health insurance system ("Sécurité Sociale")
Who may not be able to join:
- People already enrolled in another research study
- People whose personal situation the trial investigator considers incompatible with taking part
- People who live outside the Alpes-Maritimes or Var regions of France
- People who do not agree to give their consent to participate
- People who are under court-ordered restrictions on their freedom, or who are under legal guardianship or curatorship
- People with severe liver disease (specifically decompensated cirrhosis rated Child C or above)
- People with moderate-to-severe chronic kidney disease (kidney filtration rate below 59 ml/min/1.73 m²)
- People who have had a bone fracture within the last 3 months
- People currently being treated with blood-thinning medications called AVK (such as warfarin) or bone-strengthening medications called bisphosphonates
- People with a known and treated diagnosis of osteoporosis
- People with a vitamin D deficiency that is not being treated with supplements
- People with an active cancer diagnosis
- People with an active inflammatory condition
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0492034702
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measurement of plasma inorganic pyrophosphate level
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.